DEVELOPMENT OF CANINE IMMUNOTHERAPY TARGETED AGENTS

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

The Division of Cancer Treatment and Diagnosis, NCI is requesting support for the development and production of canine-specific agonists and/or antagonist antibodies to support immunotherapy studies in companion canines